|Type of research proposal requests||
|Research under MTA|
Up to US$50,000/project/year
Up to US$20,000/project/year
None (grant of compound)
3:00AM , Jan. 7, 2019 GMT to 8:00AM , Feb. 22, 2019 GMT
For each application category, please read check the following.
Submitted proposals on the research topics requested by Asahi Kasei Pharma will selected based on a comprehensive evaluation of conformity to the requested topic, originality and usefulness of research content, research plan viability, and conflict with Asahi Kasei Pharma internal projects. We are inviting applications for proposals of new drug candidates and drug development technologies and core technologies for addressing challenges in Asahi Kasei Pharma’s drug development research.
We are offering up to US$50,000 /project/year (funding will be decided in consultation for each project).
After concluding a research collaboration contract, joint research will be pursued for a period of one year (as a general rule).
Even if a proposal does not meet Asahi Kasei Pharma’s criteria for “research collaboration” category descrived above, if we decide that the proposal is original and potentially useful to the company’s drug development efforts in the future, we may offer financial assistance to support the project.
Up to US$20,000/project/year. The amount is decided after consultation for each project.
Contracts are different to those of general research collaborations. After a contract is concluded, the supported research is generally pursued for one year.
Asahi Kasei Pharma will typically have preferential negotiating rights for the research findings. If you obtain useful research findings Asahi Kasei Pharma require at the end of the first year of research, Asahi Kasei Pharma may continue involvement by proposing to extend the research incubation agreement for a second year, or by proposing a research collaboration for the next year. The details of research incubation will be decided in consultation after the selection process, and they will be defined in the contract.
Asahi Kasei Pharma provides a compound which has been obtained in the course of our internal past program for free. You use the compound as a tool to explore new target diseases involving the compound.
Asahi Kasei Pharma does not provide any funds in this category.
Research style and period: An MTA contract is concluded, and the research period is generally one year from the time the contract is signed.
After the end of the research period, if research findings that match the direction of Asahi Kasei Pharma’s R&D efforts are obtained, all rights with regard to the research findings may be basically transferred to Asahi Kasei Pharma at a price.
This inquiry form is only for application-related inquiries. Our representative will answer inquiries.
To submit other kinds of inquiries to Asahi Kasei Pharma, please click here.
Click “Apply” to proceed to the application form.